Creso Pharma


The Valens Company Inc.

TSE: VLNS


Canadian symbol: VLNS.TO
US symbol: VLNCF

Currency in CAD

Valuation Measures

Market Cap (intraday) 5393.62M
Enterprise Value 3387.65M
Trailing P/E N/A
Forward P/E 137.86
PEG Ratio (5 yr expected) 1-1.07
Price/Sales (ttm)4.70
Price/Book (mrq)2.69
Enterprise Value/Revenue 34.63
Enterprise Value/EBITDA 7-37.30

Trading Information

Stock Price History

Beta (5Y Monthly) 1.72
52-Week Change 36.00%
S&P500 52-Week Change 349.51%
52 Week High 33.1300
52 Week Low 31.4400
50-Day Moving Average 32.1906
200-Day Moving Average 31.9320

Share Statistics

Avg Vol (3 month) 31.12M
Avg Vol (10 day) 3695.63k
Shares Outstanding 5148.54M
Implied Shares Outstanding 6N/A
Float 140.13M
% Held by Insiders 112.37%
% Held by Institutions 115.65%
Shares Short (Mar. 30, 2021) 41.72M
Short Ratio (Mar. 30, 2021) 42.03
Short % of Float (Mar. 30, 2021) 4N/A
Short % of Shares Outstanding (Mar. 30, 2021) 41.16%
Shares Short (prior month Feb. 25, 2021) 41.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov. 29, 2020
Most Recent Quarter (mrq)Nov. 29, 2020

Profitability

Profit Margin -24.69%
Operating Margin (ttm)-24.67%

Management Effectiveness

Return on Assets (ttm)-8.02%
Return on Equity (ttm)-15.90%

Income Statement

Revenue (ttm)83.78M
Revenue Per Share (ttm)0.66
Quarterly Revenue Growth (yoy)-47.60%
Gross Profit (ttm)27.54M
EBITDA -10.39M
Net Income Avi to Common (ttm)-20.68M
Diluted EPS (ttm)-0.1620
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.38M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)13.39M
Total Debt/Equity (mrq)10.51
Current Ratio (mrq)3.95
Book Value Per Share (mrq)0.99

Cash Flow Statement

Operating Cash Flow (ttm)-14.65M
Levered Free Cash Flow (ttm)-34.48M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
VLNS.TO
Valens
4 weeks ago
VLNS.TO
Valens
4 weeks ago
VLNS.TO
Valens
1 month ago
VLNS.TO
Valens
1 month ago
VLNS.TO
Valens
1 month ago
VLNS.TO
Valens
1 month ago
VLNS.TO
Valens
1 month ago
VLNS.TO
Valens
1 month ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
2 months ago
VLNS.TO
Valens
3 months ago
VLNS.TO
Valens
4 months ago
VLNS.TO
Valens
4 months ago
VLNS.TO
Valens
5 months ago
VLNS.TO
Valens
5 months ago
VLNS.TO
Valens
5 months ago
VLNS.TO
Valens
5 months ago
VLNS.TO
Valens
7 months ago
VLNS.TO
Valens
7 months ago
VLNS.TO
Valens
7 months ago
VLNS.TO
Valens
7 months ago
VLNS.TO
Valens
8 months ago
VLNS.TO
Valens
8 months ago
VLNS.TO
Valens
8 months ago
VLNS.TO
Valens
8 months ago
VLNS.TO
Valens
8 months ago
VLNS.TO
Valens
8 months ago
VLNS.TO
Valens
9 months ago
VLNS.TO
Valens
9 months ago
VLNS.TO
Valens
9 months ago
VLNS.TO
Valens
9 months ago
VLNS.TO
Valens
9 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
10 months ago
VLNS.TO
Valens
12 months ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago
VLNS.TO
Valens
1 year ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Feb 2021)Next Qtr. (May 2021)Current Year (2021)Next Year (2022)
No. of Analysts1144
Avg. Estimate-0.04-0.03-0.060.07
Low Estimate-0.04-0.03-0.080.04
High Estimate-0.04-0.03-0.030.09
Year Ago EPS0.040.02-0.12-0.06
Revenue EstimateCurrent Qtr. (Feb 2021)Next Qtr. (May 2021)Current Year (2021)Next Year (2022)
No. of Analysts5587
Avg. Estimate20.8M25.32M110.9M187.06M
Low Estimate19.9M23.1M65.1M164.4M
High Estimate21.4M27.4M130.85M219.52M
Year Ago Sales32.98M17.63M83.78M110.9M
Sales Growth (year/est)-36.90%43.60%32.40%68.70%
Earnings History2019-11-292020-02-282020-08-302020-11-29
EPS Est.0.050.07-0.03-0.05
EPS Actual0.040.02-0.02-0.09
Difference-0.01-0.050.01-0.04
Surprise %-20.00%-71.40%33.30%-80.00%
EPS TrendCurrent Qtr. (Feb 2021)Next Qtr. (May 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.04-0.03-0.060.07
7 Days Ago-0.04-0.03-0.060.07
30 Days Ago-0.04-0.03-0.060.07
60 Days Ago-0.03-0.03-0.020.1
90 Days Ago-0.03-0.020.090.25
EPS RevisionsCurrent Qtr. (Feb 2021)Next Qtr. (May 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVLNS.TOIndustrySector(s)S&P 500
Current Qtr.-200.00%N/AN/AN/A
Next Qtr.-250.00%N/AN/AN/A
Current Year50.00%N/AN/AN/A
Next Year216.70%N/AN/AN/A
Next 5 Years (per annum)32.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
12.37%% of Shares Held by All Insider
15.65%% of Shares Held by Institutions
17.86%% of Float Held by Institutions
17Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
AdvisorShares Investments, LLC803,883Dec. 30, 20200.50%1,326,406
Nbw Capital Llc243,820Dec. 30, 20200.15%402,303
Albert D Mason Inc22,670Dec. 30, 20200.01%37,405

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
ETF Managers Tr-EFTMG Alternative Harvest ETF10,985,562Dec. 30, 20206.89%18,126,177
Global X Fds-The Global X Cannabis ETF3,495,017Feb. 27, 20212.19%6,046,379
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF1,832,580Mar. 30, 20211.15%4,984,617
Spinnaker ETF Tr-Cannabis ETF690,277Nov. 29, 20200.43%1,380,554
Cambria ETF Tr-Cambria Cannabis ETF123,321Feb. 27, 20210.08%213,345
American Growth Fund Inc. American Growth Cannabis Fund8,000Jan. 30, 20210.01%14,240
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by The Valens Company Inc.


The Valens Company Expands Cannabis Distribution Network with Entry into Manitoba Market

The Valens Company Expands Cannabis Distribution Network with Entry into Manitoba Market

Valens' distribution network now includes five Canadian provinces with additional expansion expected in the short-term KELOWNA, BC, April 7, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that it has entered into an ... Read More...
The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021

KELOWNA, BC, April 1, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its first quarter 2021 financial results for the period ended February 28, 2021, on Wednesday, April 14, 2021, after markets cl... Read More...
The Valens Company and Verse Cannabis Roll Out Products at Medical Cannabis by Shoppers Inc.

The Valens Company and Verse Cannabis Roll Out Products at Medical Cannabis by Shoppers Inc.

Select products from the Verse Originals and Verse Concentrates lines will be available in the coming weeks across Canada through the national medical cannabis retail platform  KELOWNA, BC, March 17, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a leading manufacturer of cannabis produ... Read More...
The Valens Company Enters First Pre-Roll Manufacturing Agreement with Experion Biotechnologies, Partner of Recently Acquired LYF Food Technologies Inc.

The Valens Company Enters First Pre-Roll Manufacturing Agreement with Experion Biotechnologies, Partner of Recently Acquired LYF Food Technologies Inc.

KELOWNA, BC, March 11, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that it has entered into a custom manufacturing agreement with Experion Biotechnologies Inc. (TSX-V: EXP) (OTCQB: EXPFF) ("Experion"), a partner of... Read More...
The Valens Company Closes Acquisition of LYF Food Technologies Inc. and Enters Edibles Category with Launch of Soft Chews

The Valens Company Closes Acquisition of LYF Food Technologies Inc. and Enters Edibles Category with Launch of Soft Chews

Creating one of the leading cannabis consumer packaged goods platforms in Canada Integration already gaining traction with launch of soft chews in partnership with A1 Cannabis and Verse Cannabis  KELOWNA, BC, March 5, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading ma... Read More...
The Valens Company Enters into Extraction and Custom Manufacturing Agreement with Rubicon Organics

The Valens Company Enters into Extraction and Custom Manufacturing Agreement with Rubicon Organics

Two of the largest certified organic producers in Canada come together to bring innovative and high-quality products to market KELOWNA, BC, March 3, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that it has entered i... Read More...
The Valens Company Reports Financial Results for the Fourth Quarter and Fiscal Year Ended November 30, 2020

The Valens Company Reports Financial Results for the Fourth Quarter and Fiscal Year Ended November 30, 2020

Strategic transformation from industry-leading extractor to largest third-party cannabis product manufacturer in Canada driving 292% Q4 2020 provincial sales growth Increased Cannabis 2.0 market share to ~4.9% in Alberta, British Columbia and Ontario based on Headset data, not including B2B LP manufacturing Valens reiterates Q1 2021 reve... Read More...
The Valens Company Submits Site Evidence Package to Health Canada for Manufacturing Facility in Greater Toronto Area

The Valens Company Submits Site Evidence Package to Health Canada for Manufacturing Facility in Greater Toronto Area

KELOWNA, BC, Feb. 23, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that it has submitted a site evidence package to Health Canada under its existing micro-processing licence application for the Company's third facil... Read More...
The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

KELOWNA, BC, Feb. 18, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis derivative products, is pleased to announce it will issue its fourth quarter and fiscal year 2020 financial results for the period ended November 30, 2020, on Wednesday, Febr... Read More...
The Valens Company Expands Product Distribution Capabilities with Amended Health Canada Licence to Sell Dried Cannabis Products

The Valens Company Expands Product Distribution Capabilities with Amended Health Canada Licence to Sell Dried Cannabis Products

Licence will allow Valens to sell and distribute pre-rolls and dried cannabis derivative products, expected to begin in Q2 2021 KELOWNA, BC, Feb. 12, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis derivative products, has received an amendment... Read More...
The Valens Company Adds CBD 100 to nūance Product Lineup Created for Medical Cannabis by Shoppers Inc.

The Valens Company Adds CBD 100 to nūance Product Lineup Created for Medical Cannabis by Shoppers Inc.

KELOWNA, BC, Feb. 11, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a leading manufacturer of cannabis derivative products, today announced the launch of nūance's CBD 100, a high-potency CBD-dominant oil, available in the Medical Cannabis by Shoppers™ marketplace in the coming weeks. CB... Read More...
The Valens Company Announces CDN$35 Million Bought Deal Offering of Units and Filing of Preliminary Base Shelf Prospectus

The Valens Company Announces CDN$35 Million Bought Deal Offering of Units and Filing of Preliminary Base Shelf Prospectus

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./KELOWNA, BC, Jan. 25, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis derivative products, is pleased to announce that it has entered into an a... Read More...
The Valens Company Expands Cannabis 2.0 & 3.0 Footprint with the Acquisition of Leading Canadian Edibles Manufacturer LYF Food Technologies Inc.

The Valens Company Expands Cannabis 2.0 & 3.0 Footprint with the Acquisition of Leading Canadian Edibles Manufacturer LYF Food Technologies Inc.

Combined industry experience, existing and deep supply chain relationships, and unique IP formulations create one of the leading cannabis consumer packaged goods platforms in CanadaUpfront purchase of LYF for CDN$24.9 million plus approximately CDN$17.5 million in consideration subject to achieving certain EBITDA milestones, which if met ... Read More...
The Valens Company Joins the Largest Voice of the CPG Industry in the Country - Food, Health & Consumer Products (FHCP) of Canada

The Valens Company Joins the Largest Voice of the CPG Industry in the Country – Food, Health & Consumer Products (FHCP) of Canada

KELOWNA, BC, Jan. 14, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a leading manufacturer of cannabis derivative products, announced today that it has become an Associate Corporate Member of Food, Health & Consumer Products of Canada (FHCP), the largest voice of the Canadian food, ... Read More...
The Valens Company CEO to Participate in ATB Capital Markets' 9th Annual Institutional Investor Conference

The Valens Company CEO to Participate in ATB Capital Markets’ 9th Annual Institutional Investor Conference

KELOWNA, BC, Jan. 11, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce that Tyler Robson, CEO of The Valens Company, will participate in the ATB Capital Markets... Read More...
The Valens Company and Verse Cannabis Add THC and CBD Drops to Verse Originals Product Line

The Valens Company and Verse Cannabis Add THC and CBD Drops to Verse Originals Product Line

KELOWNA, BC, Jan. 6, 2021 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the launch of THC and CBD water-soluble drops under a custom manufacturing agreement with Verse C... Read More...
The Valens Company Receives Health Canada License Amendment to Commence Operations at Second White Label and Custom Manufacturing Facility in Kelowna

The Valens Company Receives Health Canada License Amendment to Commence Operations at Second White Label and Custom Manufacturing Facility in Kelowna

KELOWNA, BC, Nov. 23, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, announced that it has received an amendment to its existing Health Canada standard processing licence ... Read More...
The Valens Company Awarded Wholesale Licences to Sell and Supply Cannabis-Derived Medical Products in Australia

The Valens Company Awarded Wholesale Licences to Sell and Supply Cannabis-Derived Medical Products in Australia

KELOWNA, BC, Nov. 3, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that the Victoria State Government in Australia has granted its wholly-owned subsidiary, Valens A... Read More...
Valens Co., Inc. to Host Earnings Call

Valens Co., Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 15, 2020/ Valens Co., Inc. (TSX:VLNS) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 15, 2020 at 11:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/event/presentation/68617To ... Read More...
The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020

The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020

KELOWNA, BC, Oct. 14, 2020 - The Valens Company Inc.  (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its third quarter financial results for the period ended August 31, 2020. Key Fi... Read More...
The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020

The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020

KELOWNA, BC, Oct. 6, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its third quarter 2020 financial results, for the period ended Aug... Read More...
The Valens Company and TREC Brands Launch Vape Cartridges Under WINK's Premium Product Portfolio

The Valens Company and TREC Brands Launch Vape Cartridges Under WINK’s Premium Product Portfolio

KELOWNA, BC, Oct. 1, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the launch of vape cartridges under a custom manufacturing agreement with TREC Brands for its WIN... Read More...
The Valens Company Launches Cannabis-Infused Beverage Containing 10mg of THC in Partnership with A1 Cannabis

The Valens Company Launches Cannabis-Infused Beverage Containing 10mg of THC in Partnership with A1 Cannabis

KELOWNA, BC, Sept. 29, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the launch of a new higher potency cannabis-infused beverage, Summit 10, under a white label ag... Read More...
The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020

The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020

KELOWNA, BC, Sept. 18, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that 56 white label and custom manufacturing product SKUs were produced in the third quarter of... Read More...
The Valens Company Granted Health Canada Research Licence to Conduct Human Administration Trials for Sensory and Taste Evaluation of Products

The Valens Company Granted Health Canada Research Licence to Conduct Human Administration Trials for Sensory and Taste Evaluation of Products

KELOWNA, BC, Aug. 19, 2020 - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannab... Read More...
The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces

The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces

The sativa-dominant Tropic Lemon 0.3g and 1g 510 thread vape cartridges are the first to launch under Verse Originals, a line of universal cannabis products offered at a great value. Crafted with botanical terpenes, the 0.3g value cartridges are now available in Alberta, with British Columbia, Ontario and Saskatchewan expected to follow,... Read More...
The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020

The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020

KELOWNA, BC, July 15, 2020 - The Valens Company Inc.  (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its second quarter financial results for the period ended May 31, 2020. Key Financial High... Read More...
The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

KELOWNA, BC , July 13, 2020 - The Valens Company Inc. (VLNS.TO) (VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced its participation in a Medical Cannabis Real-World Evidence Study (the "MC-RWE Study") led by Dr. Hance ... Read More...
The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020

The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020

KELOWNA, BC, July 6, 2020 - The Valens Company Inc. (formerly Valens GroWorks Corp.) (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its second quarter 2020 financial... Read More...
The Valens Company Completes Final Step in Rebrand

The Valens Company Completes Final Step in Rebrand

KELOWNA, BC, June 22, 2020 - The Valens Company Inc. (formerly Valens GroWorks Corp.) (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that it has completed its continuance out of British Columbia a... Read More...
The Valens Company Signs Custom Manufacturing Agreement with Vancouver-Based FPS Brands to Launch ufeelu

The Valens Company Signs Custom Manufacturing Agreement with Vancouver-Based FPS Brands to Launch ufeelu

KELOWNA, BC, June 18, 2020 - Valens GroWorks Corp. (TSX: VLNS) (OTCQX: VLNCF) ("Valens" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced it has signed a custom manufacturing agreement with Vancouver-based boutique brand house, FPS Brands In... Read More...
The Valens Company Enters Agreement with Cannabis-Focused CPG Company High12 Brands to Launch Premium Line of Vape Products Under DAIZE Brand

The Valens Company Enters Agreement with Cannabis-Focused CPG Company High12 Brands to Launch Premium Line of Vape Products Under DAIZE Brand

KELOWNA, BC, June 15, 2020 - Valens GroWorks Corp. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced a custom manufacturing agreement (the "High12 Agreement") with High12 Brands ("High12"), a cannabi... Read More...
The Valens Company and BRNT Launch Premium Vape Line "Made By" and Expand Custom Manufacturing Agreement

The Valens Company and BRNT Launch Premium Vape Line “Made By” and Expand Custom Manufacturing Agreement

KELOWNA, BC , June 8, 2020 - Valens GroWorks Corp. (VLNS.TO) (VLNCF) ("Valens" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the launch of a premium vape line, "Made By," in partnership with BRNT Ltd. ("BRNT"), in addition to a strategic... Read More...
The Valens Company Announces Custom Manufacturing Agreement with Next Generation Product Innovator, Verse Cannabis, To Launch Largest, Ultra Premium Concentrate Offering in Canada

The Valens Company Announces Custom Manufacturing Agreement with Next Generation Product Innovator, Verse Cannabis, To Launch Largest, Ultra Premium Concentrate Offering in Canada

Under the initial five-year agreement, The Valens Company will manufacture a range of innovative, new products, including hydrocarbon-derived crumble, one of first such entries into the Canadian legal market. Two initial product lines will be launched. First, the Verse Concentrates line will be introduced with crumble and an innovation-... Read More...
The Valens Company Nominates Three New Independent Directors to Board and Provides Update on SEDI Filings

The Valens Company Nominates Three New Independent Directors to Board and Provides Update on SEDI Filings

KELOWNA, BC, May 20, 2020 - Valens GroWorks Corp. (TSX: VLNS) (OTCQX: VLNCF) ("Valens" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced three new nominees to stand for election to its Board of Directors (the "Board") at the Annual and Speci... Read More...
C-Suite At The Open: Jeffrey Fallows, President, The Valens Company tells his Company's Story. Filmed on April 9, 2020

C-Suite At The Open: Jeffrey Fallows, President, The Valens Company tells his Company’s Story. Filmed on April 9, 2020

TORONTO , April 16, 2020 - https://youtu.be/NcVC2TNAjIIThe C-Suite At the Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest C-Suite At The Op... Read More...
The Valens Company Secures DTC Eligibility

The Valens Company Secures DTC Eligibility

KELOWNA, BC, Jan. 16, 2020 - Valens GroWorks Corp (TSXV: VLNS) (OTCQX: VLNCF) (the "Company", "Valens" or "The Valens Company"), a vertically integrated provider of industry-leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredi... Read More...
The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'

The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to ‘VLNCF’

Valens announces four-year extraction and white label agreement with Emerald Health Therapeutics Inc. with annual minimum quantities of 10,000 kilograms Valens enters into multi-year distillate and SōRSE emulsion supply agreement with large-scale confectionary company, Dynaleo Inc. Valens agreements containing white label services o... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
VLNS.TO
The Toronto Stock Exchange
The Toronto Stock Exchange2.65CAD-0.38%
7LV.F
Frankfurt Stock Exchange
Frankfurt Stock Exchange1.75EUR-5.85%
VLNCF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market2.11USD--
7LV.BE
Berlin Stock Exchange
Berlin Stock Exchange1.78EUR-4.41%
VLNS.GO
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities2.64CAD0.00%
7LV.SG
Stuttgart Stock Exchange
Stuttgart Stock Exchange1.74EUR-7.20%
VLNCF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L22.11USD-4.95%

Delayed data (1h)
NameAgePositionAppointed
Jeffrey William Fallows
President
--President2019
Tyler Robson
Chief Executive Officer, Director
--Chief Executive Officer, Director2017
Christopher Buysen
Chief Financial Officer
--Chief Financial Officer2020
Chantel Popoff
Chief Operating Officer
--Chief Operating Officer2018
Everett Knight
Executive Vice-President - Corporate Development & Capital Markets
--Executive Vice-President - Corporate Development & Capital Markets2019
Deepak Satish Anand
Independent Director
--Independent Director2019
Andrew Cockwell
Independent Director
--Independent Director--
Nitin Kaushal
Independent Director
55Independent Director2018
Karin McCaskill
Independent Director
--Independent Director--
Ashley Ervin McGrath
Independent Director
--Independent Director2018


Share this page